Brief: International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson's disease
09/05/2017 13:30
May 9 (Reuters) - International Stem Cell Corp ISCO.PK :
* International Stem Cell Corporation receives approval to
start second patient cohort in clinical trial for parkinson's
disease
* International Stem Cell Corp - DSMB has authorized
clinical trial to move forward with accelerated enrollment and
dose escalation to second cohort
Source text for Eikon: ID:nGNXNUTFSa
Further company coverage: ISCO.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on International Stem Cell
See all newsBayer says Parkinson's stem cell therapy improves symptoms in initial trial
Brief: International Stem Cell Corp posts positive interim clinical results for Parkinson's disease clinical trial
Brief: International Stem Cell to expand its revenue generating biomedical businesses
Brief: International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson's disease
Brief: International Stem Cell Q3 revenue falls 9 pct to $1.94 mln